153 related articles for article (PubMed ID: 12448868)
1. An epidemiologic study of hepatocellular carcinoma in Canada.
elSaadany S; Tepper M; Mao Y; Semenciw R; Giulivi A
Can J Public Health; 2002; 93(6):443-6. PubMed ID: 12448868
[TBL] [Abstract][Full Text] [Related]
2. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
Thein HH; Walter SR; Gidding HF; Amin J; Law MG; George J; Dore GJ
J Viral Hepat; 2011 Jul; 18(7):e232-41. PubMed ID: 21692938
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma in Australia 1982-2014: Increasing incidence and improving survival.
Wallace MC; Preen DB; Short MW; Adams LA; Jeffrey GP
Liver Int; 2019 Mar; 39(3):522-530. PubMed ID: 30230194
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity.
Seeff LB; Hoofnagle JH
Oncogene; 2006 Jun; 25(27):3771-7. PubMed ID: 16799618
[TBL] [Abstract][Full Text] [Related]
5. Comparison of clinical manifestations and outcomes between hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: analysis of a nationwide cohort.
Sinn DH; Gwak GY; Cho J; Paik SW; Yoo BC
PLoS One; 2014; 9(11):e112184. PubMed ID: 25372403
[TBL] [Abstract][Full Text] [Related]
6. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
7. Trends in incidence of hepatocellular carcinoma, 1990-2009, Khon Kaen, Thailand.
Wiangnon S; Kamsa-ard S; Suwanrungruang K; Promthet S; Kamsa-ard S; Mahaweerawat S; Khuntikeo N
Asian Pac J Cancer Prev; 2012; 13(3):1065-8. PubMed ID: 22631639
[TBL] [Abstract][Full Text] [Related]
8. Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan.
Tsai MC; Kee KM; Chen YD; Lin LC; Tsai LS; Chen HH; Lu SN
J Gastroenterol Hepatol; 2007 Jan; 22(1):92-8. PubMed ID: 17201888
[TBL] [Abstract][Full Text] [Related]
9. Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study.
Gjærde LI; Shepherd L; Jablonowska E; Lazzarin A; Rougemont M; Darling K; Battegay M; Braun D; Martel-Laferriere V; Lundgren JD; Rockstroh JK; Gill J; Rauch A; Mocroft A; Klein MB; Peters L
Clin Infect Dis; 2016 Sep; 63(6):821-829. PubMed ID: 27307505
[TBL] [Abstract][Full Text] [Related]
10. Risk of hepatobiliary disease in adults with severe alpha 1-antitrypsin deficiency (PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma?
Elzouki AN; Eriksson S
Eur J Gastroenterol Hepatol; 1996 Oct; 8(10):989-94. PubMed ID: 8930564
[TBL] [Abstract][Full Text] [Related]
11. Profile of hepatocellular carcinoma in the Republic of Moldova: first-hand information on the presentation, distribution and etiologies.
Turcanu A; Pitel E; Dumbrava VT; Tcaciuc E; Donscaia A; Peltec A; Pineau P
Rom J Intern Med; 2019 Mar; 57(1):37-46. PubMed ID: 30375353
[TBL] [Abstract][Full Text] [Related]
12. Burden of virus-associated liver cancer in the Arab world, 1990-2010.
Khan G; Hashim MJ
Asian Pac J Cancer Prev; 2015; 16(1):265-70. PubMed ID: 25640363
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study.
Davila JA; Morgan RO; Shaib Y; McGlynn KA; El-Serag HB
Gastroenterology; 2004 Nov; 127(5):1372-80. PubMed ID: 15521006
[TBL] [Abstract][Full Text] [Related]
14. The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa.
Kirk GD; Lesi OA; Mendy M; Akano AO; Sam O; Goedert JJ; Hainaut P; Hall AJ; Whittle H; Montesano R
Hepatology; 2004 Jan; 39(1):211-9. PubMed ID: 14752840
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma: an epidemiologic view.
El-Serag HB
J Clin Gastroenterol; 2002; 35(5 Suppl 2):S72-8. PubMed ID: 12394209
[TBL] [Abstract][Full Text] [Related]
16. Increasing incidence and mortality related to liver cancer in Australia: time to turn the tide.
Cocker F; Chien Yee K; Palmer AJ; de Graaff B
Aust N Z J Public Health; 2019 Jun; 43(3):267-273. PubMed ID: 30958629
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma incidence trends in Canada: analysis by birth cohort and period of diagnosis.
Pocobelli G; Cook LS; Brant R; Lee SS
Liver Int; 2008 Nov; 28(9):1272-9. PubMed ID: 18384523
[TBL] [Abstract][Full Text] [Related]
18. Review article: the changing epidemiology of hepatocellular carcinoma in Canada.
Dyer Z; Peltekian K; van Zanten SV
Aliment Pharmacol Ther; 2005 Jul; 22(1):17-22. PubMed ID: 15963075
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus-related complications are increasing in women veterans: A national cohort study.
Kramer JR; El-Serag HB; Taylor TJ; White DL; Asch SM; Frayne SM; Cao Y; Smith DL; Kanwal F
J Viral Hepat; 2017 Nov; 24(11):955-965. PubMed ID: 28815822
[TBL] [Abstract][Full Text] [Related]
20. Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus.
Tanaka H; Tsukuma H; Yamano H; Oshima A; Shibata H
Int J Cancer; 2004 Dec; 112(6):1075-80. PubMed ID: 15386355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
